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ABSTRACT 
Molecular docking analysis was carried out to understand better the interaction between 
DHODH and inhibitor from nutmeg in this series. The nutmeg constituent binding orientations in 
the active site of DHODH was seen in a molecular docking analysis and helped design a 
potentially new inhibitor. This work aimed to study the molecular docking of nutmeg constituents 
with the DHODH inhibitor using a computer-aided drug design. Molecular docking using AutoDock 
4.2 was done to explore the models of binding complexes. The 3D structure was derived using 
Discovery Studio to investigate the essential chemical interaction of complex structures. 
Dihydroguaiaretic acid was the most potent ligand having a docking score of -9.3 kcal/mol. This 
value was better than the standard drug 5-FU. The dihydroguaiaretic acid structure interacted 
with Tyr365 and Thr63 through a hydrogen bond similar to the native ligand. These results 
suggest that nutmeg seed could serve as the lead compound for potent DHODH inhibitors against 
skin. 
 




Nutmeg (Myristica fragrans) extracted 
from the seed of nutmeg used for medicinal 
purposes [1]. Nutmeg oil is acquired from the 
seed of nutmeg fruit. The essential oil from 
nutmeg seeds has anticarcinogenic activity 
[2]. Studies on the nutmeg seed have 
reported extracts and many compounds with 
anti-cancer and antioxidants activities [3,4]. 
A flavonoid found in nutmeg shows 
that anti-cancer potent effects, mostly on UV-
B, cause skin cancer, but molecular 
mechanisms and targets are open to 
questions [5]. Skin cancer in 2018 is the 
second biggest cancer cause of death 
worldwide, with new cases, approximately 
9.88 million, and 1.08 million were monitored. 
Melanoma cancer rapidly increases than 
nonmelanoma cancer because of environ-
mental changes. Skin cancer/melanoma is 
rising in current years due to exposure to UV 
radiation. Almost the aggressiveness of skin 
cancer caused by exposure to an excess of 
UV radiation from the sun [6]. 




(DHODH), located in the internal mito-
chondrial membrane, plays a key function in 
the programming of UV-B induced energy. 
DHODH catalyzes the transformation of 
dihydroorotate in the fourth step of the six 
enzyme reactions of this pathway as the rate-
limiting enzyme in the de novo pyrimidine 
synthesis pathway. DHODH up-regulation 
was crucial for sustaining higher activity in the 
radiated skin of the electron transport chain 
and for coordinating ATP generation [7]. 
Enhanced DHODH activity was involved as a 
biomarker for malignant tumours, including 
skin cancer. Ultraviolet radiation can induce 
DHODH expression transcriptionally by 
triggering STAT-3 [8]. DHODHODH inhibitors 
affect ATP depletion and endogenous ROS 
levels. A DHODH inhibitor proved an anti-
tumour treatment effect in conjunction with 
fluorouracil [9]. DHODHODH inhibitors have 
great potential to be used for cancer 
treatment [9-13]. 
Melanoma skin cancer has a strong 
potency to grow to other parts of the body, 
and it becomes difficult to cure. The WHO 
reports that 132,000 cases of skin cancer 
happen on an annual basis. In 2016, 
approximately 76,380 skin cancer cases will 
be invading melanomas, with about 46,870 in 
males and 29,510 in women. There will be an 
annual increase of skin cancer impact by 
4500 due to the 10% devastation of the 
ozone layer [14]. 
The invention of new bioactive 
compounds shows highly selective anti-
cancer activity is of high order for cancer 
treatment. Possible anti-cancer activities of 
myristicin were predicted by computer-
based molecular docking. This study 
includes molecular docking of myristicin 
from nutmeg against active centres of 
cancer-related DHODH [14]. New research 
is still required in finding new compounds for 
skin cancer. Finding a specific target drug is 
one of the most effective ways to inhibit skin 
cancer [15]. 
Molecular docking is a tool for 
predicting small molecules' binding 
orientation from drug candidates to their 
protein targets to predict the activity and 
affinity. Molecular docking plays a major role 
in the design of drugs. Autodock is one of the 
programs used to perform docking [16]. 
Several molecular docking works from 
phytochemical constituents for anti-cancer 
have been published elsewhere [17] [18] [19]. 
The molecular docking of nutmeg constituent 
toward DHODH for skin cancer has never 
been reported before. 
The investigation of the binding site 
between the DHODH receptor and the 
selected structure from nutmeg was done. A 
docking score evaluation was also carried out 
for investigating the anti-cancer activity. This 
research examines the interaction binding 
site between nutmeg seed constituents and 
DHODH as anti-skin cancer agents. 
 
METHODS 
The ligands and receptor protein were 
prepared using Chimera 1.13.1 and Autodock 
4.2.6 (The Scripps Research Institute, USA). 
Autodock Tools (ADT) 1.5.6 were used for 
the docking analysis. Computational 
visualization was performed using Discovery 
Studio (BIOVIA Discovery Studio 2019). The 
hardware used was Asus VivoBook Intel 
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Core i3-7020u, 4GB RAM, and 500GB hard 
disk using OS Windows 10.  
The 3D structure of 20 ligands from 
nutmeg constituents was obtained using the 
Pubchem web database. The ligand was 
prepared to pdbqt format using Chimera 
1.13.1. The 3D structure of DHODH was 
obtained from Protein Data Bank 
(www.rscb.org/pdb) using PDB ID (PDB 
entry: 2BXV) [20], resolution of 2.15 Å, 
organism Homo sapiens) in the database. 
The receptor protein was prepared using 
Chimera 1.13.1. All water molecules were 
removed, and hydrogen atoms were added. 
The binding mode of the nutmeg seed 
active compound into the target of DHODH 
was investigated using molecular docking 
[21]. The pdbqt files for protein and ligands 
preparation and generating the grid box were 
completed using the graphical user interface 
program AutoDock Tools (ADT). AutoGrid 
was used for the preparation of the grid map 
using a grid box. The grid size was set to 
38.88×44.27×42.81 XYZ points. The ligand 
was docked into the active sites of melanoma 
skin cancer (PDB ID: 2BXV). 
Lamarckian genetic algorithm (LGA) 
was used to detect the most desirable ligand 
binding orientations. The interaction was 
produced, and the docking result of binding 
energy and residue were reported [22, 23]. 
The dock Score function was used to scoring 
all the dock ligands. Analyses were identified 
from the best pose.  
 
RESULTS AND DISCUSSION 
The application of molecular docking 
used in medicinal chemistry and drug 
discovery is predicted the interaction 
between two molecules. Docking is done 
between a small molecule drug and a large 
macromolecule receptor in drug discovery. 
Molecular mechanics apply for most docking 
program to calculate the binding energy [24]. 
Docking is useful for drug design by 
searching the optimized confirmation for the 
ligan-protein complex and their relative 
orientation. Minimum free energy in the 
overall system means the ligand is potent to 
select drug candidates [25]. There are three 
steps in molecular docking: pose prediction, 
virtual screening, and binding affinity 
calculation-Ligan conformation generated 
from the search algorithm and energy scoring 
function [26].  
Molecular docking studies in this work 
were done using the AutoDock Tools (ADT) 
1.5.6 and AutoDock 4.2.5.1 docking program. 
The docking program is used to explore the 
potential binding mode of the inhibitor from 
the nutmeg constituents. Nutmeg seeds 
essential oil have anticarcinogenic activity. 
The composition of nutmeg seed oil differ 
significantly based on their source. The 
essential oil of nutmeg seed contains 
sabinene (15-50%), a-pinene (10-22%), b-
pinene (7-18%), myrcene (0,7-3%), 1.8-
cineole (1,5-3,5%), a-phellandrene (0,3-
6.2%), myristicin (0,5-13,5%), limonene (2,7-
4,1%), eugenol (0,1-1%), safrole (0,1-3,2%), 
and terpinene-4-ol (0-11%) [27]. The 
potential chemopreventive agent in volatile oil 
is elemicin, and the most responsible for 
pharmacological effect in nutmeg is myristicin 
[28]. The main compounds in the aromatic 
essential oil are myristicin, elemicin, safrole 
(85-95%), and myristicin (4-12%) [29].  
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The algorithm of molecular docking 
had been originally tested by redocking 
ligands at the active receptor position for the 
reliability and reproductivity of the current 
docking algorithm, utilizing the root mean 
square deviation (RMSD) measurement. 
RMSD from redocking of 2XBV protein 
receptor was 1.733 Å. RMSD value less than 
2.0 Å showing the algorithm validated 
compared to the crystallographic structure 
[30]. As can be seen from the comparison of 
our RMSD with the RMSD as mentioned 
above, this research could continue using our 
validated docking protocol [31]. The RMSD 
below 2.0 Å indicates the formation of good 
quality docking method [32]. 
Molecular docking has many benefits, 
including the system's capacity to check broad 
compound databases at low costs compared to 
experiments [33]. Molecular modelling is used 
to predict the compound's possible mode and 
determine the direction of the best pose from 
the optimizing structure [34]. Twenty 
compounds from nutmeg seed were docked to 
binding sites of the DHODH target. The 
calculated binding energy corresponds to the 
anti-cancer activity [35]. The docking score and 
interaction residue of the H-bond presented in 
Table 1. The best-docked ligand was the 
malignant compound. The binding energy of 
malignant with the DHODH is -10.4 kcal/mol.  
Alpha-pinene performed low binding 
energy scores, respectively -6.0 kcal/mol. The 
low binding energy because the compound did 
not fit with the binding site of the DHODH 
receptor. The ΔG binding of 19 constituents 
from nutmeg was all greater than -7.0 kcal/mol, 
suggesting that these nutmeg constituents 
have the potential to be DHODH inhibitor.  A 
stable complex that shows greater negative 
free binding energy indicates high inhibitor 
strength [36]. Table 1 indicated that the 
selected compounds from nutmeg showed 
good anti-cancer activity compared with the 5-
fluorouracil, which is widely used in cancer 
treatment.  According to the results from the 
molecular docking studies for DHODH, all 
nutmeg seed constituents performed 
significantly better scores when compared with 
5-fluorouracil as drug standard [37] [38]. 
The docking score between DHODH 
and compound macilin F, macelignan, 
dihydroguaiaretic acid, and fragransin E1 was -
10.0, -10.4, and 9.3 and –9.7, respectively. The 
order of activity was: macelignan > macilin F > 
fragransin E1 > dihydroguaiaretic acid. The 
docking score indicates the interaction affinity 
between the receptor and ligand by the 
optimized algorithm, speculating the scope of 
inhibitory activity. The evaluation index for fast 
preliminary steps and inhibitors is the key 
importance of the docking score. 
The free binding free energy estimation 
is calculating from the docking score for the 
protein-ligand complex. The lowest energy 
score indicates the highest protein affinity with 
the best potent ligand means the best docking 
score [35]. The docking scores for each 
compound compared to the standard drug 
score. The result shows that the nutmeg 
constituents have better docking scores than 
standard drugs available in the market (5-
fluorouracil [38]. The active site exhibit that 
several molecular interactions considered in 
control of the observed affinity. After checked 
the binding score, evaluation of docking score 
based on amino acid residue between ligand-
receptor complex. 
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Table 1. Docking score of nutmeg constituents 










1 Dyclonin -9.2 Asn145 
Val143, Tyr356, Pro52, Ala55, 
Ala59 
 [39] 
2 Dihydroguaiaretic acid -9.3 Tyr356, Thr63 
Pro364, Phe98, Leu359, 
Ala59, Thr360, Ala55 
[39] 
3 Eugenol -7.0  Tyr356, Val143 [39] 
4 Fragnasol A -8.7 
Lys255, 
Thr360 
Tyr356, Val134, Val143 
[39] 
5 Fragnasol C -8.6 Glin47 
Met43, Leu42, Ala59, Leu58, 
Pro364, Leu359, Met43 
[39] 
6 Fragransin A2 -9.1  
Phe62, Leu46, Leu58, Ala59, 
Ala55 
[39] 
7 Fragransin C2 -8.5 Thr63 
Phe52, Leu42, Ala59, Tyr38, 
Pro364, Met43, Ley46 
[39] 
8 Fragransin E1 -9.7  
Arg136, Val143, Tyr356, Ala59, 
Ala55, His56, Pro52, Val143 
[39] 
9 Fragransol B -9.0 Gln47 
Met43, Pro364, Tyr356, 
Leu359, Phe98 
[39] 
10 Guaiacin -8.1 Tyr356 Ala96, Ala95 [39] 
11 Isoeugenol -7.4  Pro52, Val143, [39] 
12 Macelignan -10.4 Ala96, Gln47 
Tyr147, Val134, Tyr356, Ala55, 
Thr360, Val143, Phe62, 
Leu359, Phe98 
[39] 
13 Machilin F -10.0  Ala59, Pro364, Leu46, Leu58 [39] 
14 Methylisoeugenol -7.7 Asb145 Val143 [39] 
15 Myristic acid -6.7 
Ser305, 
Asn145 
His56, Phe98, Ala59 
[39] 
16 Myristicanol A -7.6  
Met43, Ala59, Leu42, Pro364, 
Tyr38, Pro52 
[39] 
17 Myristicanol B -8.0 
Asn284, 
Lys255 
Val143, Ala55, Ala34, Tyr147 
[39] 
18 Myristicin -7.9 Ser305 Val143, Val134, Pro52 [39] 
19 Safrole -7.6 
Asn145, 
Ser305 
Val143, Tyr356, Val135, Pro52, 
Leu42, Pro364, Ala59 
[39] 
20 Alpha-pinene -6.0  
Tyr38, Pro69, Leu68, Leu58, 
Leu46, Phe62 
[39] 
21 Native ligand -12.0 Tyr356, Thr63 
Thr360, Ala55, Leu359, Ala59, 
Tyr38, Leu42, Pro364 
[20] 







Interaction of nutmeg constituents and 
DHODH protein receptor can be seen in Table 
1. Table 1 showed interacting residue hydrogen 
bond and non-hydrogen bond from 40 nutmeg 
constituent compared with native ligand and 
drug standard.  Docking simu-lations colored 
2D-binding mode represen-tation between 
DHODH and native ligand shown in Figure 1. 
Macelignan-DHODH complex and 
dihydroguaiaretic acid-DHODH complex 
binding mode shown in Figure 2 and 3, 
respectively. The binding interactions between 
DHODH and nutmeg constituents mainly 
involve conventional hydrogen bonds, Van der 
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Walls, pi-sigma, pi-alkyl, pi-pi stacked, and 
alkyl. Molecular docking reports showed that 
the compounds would interact in DHODH 
inhibitor. The binding between the bioactive 
compounds and DHODH was verified by 
molecular docking. 
 
Figure 1. Two-dimensional interaction of 
native ligand and DHODH 
 
There is no hydrogen bond in macilin F 
and fragransin E1. They interact only through 
alkyl and π-alkyl interaction. Native ligand-
bound Tyr356 and Thr63 via hydrogen bond. 
The hydrogen bonds between Ala96, Gln47 
residues and macelignan, the pi-pi stacked 
between Thr360 and macelignan, or pi-alkyl 
bonds between Ala55, Val143, Val134, 
Tyr356, Tyr147 and macelignan, not related 
to the native ligand interaction and DHODH. 
Two-dimensional interaction of malignant 
and DHODH could be seen in Figure 2. 
The interaction of dihydroguaiaretic 
acid has two hydrogen bonds with amino acid, 
namely Thr63 and Tyr365, similar to the native 
ligand. Dihydroguaiaretic acid could strongly 
interact with Thr63 and Tyr635 via carbon-
hydrogen. This association was powered by 
the forming of hydrogen interactions between 
the receptor and the compound. The π-sigma 
interaction found in Ala59 and Thr360. The π-
alkyl interaction found in Pro364. The two-
dimensional interaction of dihydroguaiaretic 
acid could be seen in Figure 3. Dihydro-
guaiaretic acid has the best interaction in 
complex DHODH because of the amino acid 
residue similar with native ligand.  
 
Figure 2. Two-dimensional interaction of 
macelignan and DHODH 
 
 
Figure 3. Two-dimensional interaction of 
dihydroguaiaretic acid 
 
The molecular docking findings revealed 
a clear understanding and visual explanation of 
the nutmeg constituents and inhibitor binding 
mechanism. The same binding location and 
mode may be the same mechanism for 
inhibition [40]. However, the model established 
would be too early to be valid for compound 
anti-skin cancer without any experimental 
proof-the lower the energy, the stronger the 
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binding between ligand-receptor complex. 
Docking simulations of the binding position of 
nutmeg constituents in the hydrophobic pocket 
of DHODH indicates the inhibition mechanism 
on the oxidoreductase activity of DHODH. The 
combination mode and binding sites of DHODH 
and forty nutmeg compounds were studied by 
molecular simulation. Molecular docking is the 
most widely used approach for structure-based 
drug design and has many applications, such 
as binding energies and interaction [41]. The 
molecular docking method verified the good 
binding energy of 20 pairs of ligand-protein 
DHODH inhibitor complex. 
 
CONCLUSION  
The best interaction model of nutmeg 
constituents was dihydrogudiaretic acid with a 
binding energy score of -9.3 kcal/mol. The 
dihydroguaiaretic acid structure interacted with 
Tyr365 and Thr63 through a hydrogen bond 
similar to the native ligand. The result suggests 
that nutmeg seed could serve as the lead 
compound for potent DHODH inhibitor against 
skin cancer.  
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